SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-23-000075
Filing Date
2023-11-01
Accepted
2023-11-01 09:00:34
Documents
16
Period of Report
2023-11-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20231101.htm   iXBRL 8-K 34152
2 EX-10.1 samrahanewhireannnouncem.htm EX-10.1 4350
7 samrahanewhireannnouncem001.jpg GRAPHIC 169924
8 samrahanewhireannnouncem002.jpg GRAPHIC 82359
  Complete submission text file 0000899923-23-000075.txt   543573

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20231101.xsd EX-101.SCH 2140
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20231101_def.xml EX-101.DEF 14426
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20231101_lab.xml EX-101.LAB 27876
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20231101_pre.xml EX-101.PRE 15012
10 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20231101_htm.xml XML 2707
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 231366742
SIC: 2835 In Vitro & In Vivo Diagnostic Substances